Andrew Marino, MD | |
100 South St, Southbridge, MA 01550-4051 | |
(508) 765-9771 | |
(508) 764-2448 |
Full Name | Andrew Marino |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 100 South St, Southbridge, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164682423 | NPI | - | NPPES |
002266201 | Other | MA | MEDICARE PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 236789 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Andrew Marino, MD 100 South St, Southbridge, MA 01550-4051 Ph: (508) 765-9771 | Andrew Marino, MD 100 South St, Southbridge, MA 01550-4051 Ph: (508) 765-9771 |
News Archive
Ludwig Cancer Research and the Cancer Research Institute announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI (durvalumab) for advanced ovarian and colorectal cancers.
A team from The University of Texas at Arlington has used mathematical modeling to develop a computer simulation they hope will one day improve the treatment of dangerous reactions to medical implants such as stents, catheters and artificial joints.
Anthurium Solutions, Inc. (ASI), a technology and solutions company offering turnkey and custom in-the-cloud solutions that enable new health care delivery models, will present during the American Society on Aging (ASA)'s Aging in America, the largest multidisciplinary aging conference in the country.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced financial results for the quarter ended March 31, 2010, provided an update on progress towards achievement of 2010 goals as well as 2010 financial guidance.
Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted the company's Investigational New Drug (IND) application for the study of AVP-923, an investigational drug for the treatment of agitation in patients with Alzheimer's disease (AD).
› Verified 9 days ago
Dr. Carl John Vanderputten, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 South St, Harrington Memorial Hospital, Southbridge, MA 01550 Phone: 508-765-9771 Fax: 508-765-3147 | |
Dr. Kathleen Mary Finn, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 South St, Southbridge, MA 01550 Phone: 508-765-9771 Fax: 508-764-2448 | |
James C Stephens, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 South St, Southbridge, MA 01550 Phone: 508-765-9771 Fax: 508-764-2490 | |
Kathleen Cara Coan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 South St, Southbridge, MA 01550 Phone: 508-765-9771 Fax: 508-764-2448 | |
Vincent L. Kan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 South St, Southbridge, MA 01550 Phone: 508-756-9771 | |
Doreen M Norberg, NP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 South St, Southbridge, MA 01550 Phone: 508-765-9771 Fax: 508-909-7735 |